Methods of monitoring redox homeostasis and their possible role in the diagnostic practice;A szervezet redox-egyensúlyának vizsgálati módszerei, lehetséges szerepük a diagnosztikában

Orvosi Hetilap

Volumn 145, Issue 14, 2004, Pages 761-767

  Kocsis, Ibolya ^a,c   Blázovics, Anna ^a   Pallai, Zsolt ^b   Fehér, János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Diachem Kft   (Hungary)

^c NONE   (Hungary)

Author keywords

Oxidative stress; Total antioxidant status; Total scavenger capacity

Indexed keywords

ANTIOXIDANT; FREE RADICAL; BIOLOGICAL MARKER; SCAVENGER;

ARTICLE; ATHEROSCLEROSIS; CHRONIC LIVER DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; HOMEOSTASIS; KIDNEY FAILURE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TISSUE INJURY; ALCOHOL LIVER DISEASE; BLOOD; CHEMOLUMINESCENCE; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; REVIEW;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CHEMILUMINESCENT MEASUREMENTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER DISEASES, ALCOHOLIC; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 2942744452     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ames, B. N., Shigenaga, M. K., Hagan, T. M.: Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci., 1993, 90, 7915-7922.
2. Asensi, M., Sastre, J., Pallardo, F. és mtsai: Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol., 1999, 299, 267-276.
3. Blázovics, A., Kovács, Á., Lugasi, A. és mtsai: Antioxidant defence in erythrocytes and plasma of patients with active and quiescent Chron's disease and ulcerative colitis: a chemiluminescence study. Clin. Chem., 1999, 45, 895-896.
4. Britton, R., Bacon, B.: Role of free radicals in liver diseases and hepatic fibrosis. Hepato Gastroenterol., 1994, 41, 343-348.
5. Buffinton, G. D., William, F. D.: Depleted mucosal antioxidant defences in inflammatory bowel diseaese. Free Rad. Biol. Med., 1995, 19, 911-918.
6. Ceballos-Picot, I., Witko-Sarsat, V., Merad-Boudia, M. és mtsai: Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Rad. Biol. Med.,1996, 21, 845-853.
7. Ceriello, A., Bortolotti, N., Falleti, E. és mtsai: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care, 1997, 20, 194-197.
8. Chebil, S., Layach, H., Limam, H. B. és mtsai: Interest in superoxide dismutase dosage and total antioxidants in cardiopathies. Atherosclerosis 1997, 134, 210-214.
9. Clermont, G., Lecour, S., Lahet, J. és mtsai: Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res., 2000, 47, 618-623.
10. Conklin, K.: Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutrition and Cancer 2000, 37, 1-18.
11. Diaz, M., Frei, B., Vita, J. és mtsai: Antioxidants and atherosclerotic heart desase. N. Engl. J. Med., 1997, 337, 408-416.
12. Dorgan, J., Sowell, A., Swanson, C. és mtsai: Relationship of serum carotenoids, retinol, α-tocopherol and selenium with breast cancer risk results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control., 1998, 9, 89-97.
13. Eggleton, P., Wang, L., Penhallow, J. és mtsai: Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann. Rheum. Dis., 1995, 54, 916-923.
14. Emerit, J., Pelletier, S., Likforman, J. és mtsai: Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic. Res. Commun., 1991, 12-13, 563-569.
15. Fehér, J., Lengyel, G., Blázovics, A.: Oxidative stress in the liver and biliary tract diseases. Scand. J. Gastroenterol., 1998, 33 (Suppl.), 228-238.
16. Fehér, J., Csomós G., Vereckei, A.: Free Radical Reactions in Medicine. Springer-Verlag, Berlin 1985.
17. Fecondo, J., Augusteyn, R.: Superoxide dizmutase, catalase and glutathione peroxidase in human cataractous lens. Experimental Eye Research, 1983, 36, 15-23.
18. Fukai, T., Folz, R., Landmesser, U. és mtsa: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res., 2002, 55, 239-249.
19. Gavella, M.: Superoxid scavenging capacity of human seminal plasma. Int. J. Andrology, 1996, 19, 82-90.
20. Guemouri, L., Artur, Y., Herbeth, B. és mtsai: Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin. Chem, 1993, 37, 1932-1937.
21. Hagymási, K, Blázovics, A., Lengyel, G, és mtsai: Sex-dependent oxidative damage in alcoholic liver disease. Eur. J. Gastroenterol. Hepatology., 2000, 12, 1-5.
22. Irshad, M., Chaudhuri, P., Joshi, Y.: Superoxide dismutase and total antioxidant levels in various forms of liver diseases. Hepatol. Res., 2002, 23, 178-184.
23. Iwamoto, A., Egashira, T., Takayama, F. és mtsai: Change in free radical-related substances in plasma, following ischemia-reperfusion in rat liver. Pathophysiology, 2002, 8, 167-174.
24. Jacques, P., Chylack, L. Jnr.: Epidemiological evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am. J. Clin. Nutr., 1991, 53, 352S-355S.
25. Kirschbaum, B.: Total urine antioxidant capacity. Clin. Chim. Acta, 2001, 305, 167-173.
26. Koch, T., Stryker, S., Telford, G. és mtsai: Total antioxidant capacity is reduced in Crohn's disease. Nutr. Res., 2002, 22, 825-833.
27. Kristenson, M., Zieden, B., Kucinskiene, Z. és mtsai: Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. Br. J. Med., 1997, 314, 629-633.
28. th ed. Szerk.: Lee, G., Williams and Wilkins, Baltimore, MD, 1999, 240. old.
29. Masumoto, H., Seis, H.: The reaction of ebselen with peroxinitrite. Chem Res. Toxicol., 1996, 9, 262-267.
30. Matkovics, B., Gyurkovics, K., László, A. és mtsa: Altered peroxide metabolism in erythrocytes from children with cystic fibrosis. Clin. Chim. Acta., 1982, 125, 59-62.
31. Maxwell, S., Thomason, H., Sandler, D.: Antioxidant status in patients with uncomplicated insulin dependent and non-insulin dependent diabetes mellitus. Eur. J. Clin. Invest., 1997, 26, 484-490.
32. McMurray, J., Chopra, M., Abdullah, I. és mtsai: Evidence of oxidative stress in chronic heart failure in humans. Eur. Heart. J., 1993, 14, 1493-1498.
33. Morita, A., Minami, H., Sakakibara, N. és mtsai: Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J. Dermatol. Scin., 1996, 11, 196-201.
34. Ostrakovitch, E., Afanasev, I.: Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators. Biochem. Pharmacol., 2001, 62, 743-746.
35. Pincemail, J.: Free radicals and antioxidants in human desease. In Analysis of free radicals in biological systems, Szerk.: Favier, A. E., Cadet, J., Kalyanaraman, B. és mtsai Birkhauser Verlag, Basel, 1995, 83-98. old.
36. Portal, B., Richard, M., Faure, H. és mtsai: Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am. J. Clin. Nutr., 1995, 61, 843-847.
37. Prechl, J., Szaleczky, E., Pusztai, P. és mtsai: Effect of clinical duration of diabetes mellitus on various antioxidants in blood. Medical Science Monitor, 1997, 3, 167-170.
38. Purucker, E., Winograd, R., Roeb, E. és mtasi: Gluthatione status in liver and plasma during development of biliary cirrhosis after bile duct ligation. Res. Exp. Med., 1998, 4, 167-174.
39. Rice-Evans, C., Miller, N.: Total antioxidant status in plasma and body fluids. Methods Enzymol., 1994, 234, 279-293.
40. Ruan, E. A., Rao, S., Burdick, J. S. és mtsai: Glutathione in the idiopathic inflammatory bowel diseases: relationship between colonic glutathione levels, and inflammation disorders of the human colon. Nutr. Res., 1997, 17, 463-73.
41. th IFCC European Congress of Clinical Chemistry, Basel, 1997, Poster A29.
42. Salonen, J., Salonen, R., Lappetelainen, R. és mtsai: Risk of cancer in relation to serum concentrations of selenium and vitamins A and E. Matched case control analysis of prospective data. Brit. Med. J., 1995, 240, 417-420.
43. Schadendorf, D., Zuberbier, T., Diehl, S. és mtsai: Serum manganese superoxide dismutase is a new tumor marker for malignant melanoma. Melanoma Res., 1995, 5, 351-353.
44. Seghieri, G., Simplicio, P., Anichini, R. és mtsai: Platelet antioxidant enzymes in insulin-dependente diabetes mellitus. Clin. Chim. Acta, 2001, 309, 19-23.
45. Sharma, R., Agar, W.: A role of ROS in male infertility. Urology, 1996, 48, 835-850.
46. Shimomura, H., Maehata, E., Takamiya, T.: Blood extracellular superoxide dizmutase levels in hemodialysis patients pre- and post hemodialysis and its association with lipoprotein lipase mass and free fatty acid. Clin. Chim. Acta., 2003, 328, 113-119.
47. Stampfer, M., Hennekens, C., Manson, J. és mtsai: Vitamin E cosumption and the risk of coronary heart disease in women. N. Engl. J. Med., 1993, 328, 1450-1456.
48. Szilvás, Á., Blázovics, A., Székely, Gy. és mtsai: Comparative study between the free radicals and tumor markers in patients with gastrointestinal tumors. J. Physiol. Paris, 2001, 95, 247-252.
49. Taper, H., Roberfroid, M.: Non toxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutrition and Cancer, 2001, 38, 1-5.
50. Vereckei, A., Fehér, E., Blázovics. A. és mtsai: Further evidence for the role of oxidative stress in the pathogenesis of amiodarone toxicity. XXth. Congress of the European Society of Cardiology, Vienna, Austria., Eur. Heart. J., 1998. 19, (Suppl.), 91.
51. Verlangieri, A., Kapeghian, J., el-Dean, S. és mtsai: Fruit and vegetable consumption and cardiovascular disease mortality. Med. Hypotheses., 1985, 16, 7-15.
52. Yoshimura, S., Suemizu, H., Nomoto, Y. és mtsai: Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron, 1996, 73, 207-211.
53. Yücel, D., Aydogdu, S., Cehreli, S.: Increased oxidative stress in dilated cardiomyopathic heart failure. Clin. Chem., 1998, 44, 148-154.